How do I make these posts better for you.

I am not a great writer in the usual sense. I write science papers and book chapters; summarizing data for others like me who are experts in the field. So when I started this blog, I stepped out of my comfort zone. How do I communicate complex data and abstract ideas to a sophisticated but not necessarily technically advanced audience?

I want to try an experiment and see whether I should be learning how to write better from AI. So this week I present two versions of the same post focused on the potential for GLP-1 agonists (think Wegovy or Ozempic) as treatment for Parkinson's, given how the first data created so much excitement and hope, only to be followed by disappointing results in a large-scale, Phase 3 clinical trial as reported last month.

One post will be written by me. The other will be one I lightly edited after putting my original post into perplexity.ai.

Which do you like better, my current style or the perplexity-AI model?

Please vote by clicking on one link or the other - which will open your email client with a new email addressed and with your vote (which you can modify).


Share This

About Jonathan Sackner-Bernstein, MD

Dr. Sackner-Bernstein shares his pursuit of conquering Parkinson's, using expertise developed as Columbia University faculty, FDA senior official, DARPA insider and witness to the toll of PD.
Dr. S-B’s Linkedin page

RightBrainBio, Inc. was incorporated in 2022 to develop tranformative therapies for people with Parkinson's.